Nitorum Capital’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-402,100
| Closed | -$47.7M | – | 41 |
|
|
2020
Q4 | $47.7M | Buy |
402,100
+1,748
| +0.4% | +$208K | 1.85% | 29 |
|
|
2020
Q3 | $34.9M | Buy |
400,352
+4,717
| +1% | +$412K | 1.55% | 29 |
|
|
2020
Q2 | $35.4M | Buy |
395,635
+1,571
| +0.4% | +$141K | 1.82% | 23 |
|
|
2020
Q1 | $39.3M | Buy |
394,064
+113,478
| +40% | +$11.3M | 3.04% | 14 |
|
|
2019
Q4 | $32.2M | Buy |
280,586
+1,076
| +0.4% | +$124K | 1.8% | 24 |
|
|
2019
Q3 | $35.3M | Sell |
279,510
-151,300
| -35% | -$19.1M | 2.05% | 23 |
|
|
2019
Q2 | $51.8M | Buy |
430,810
+107,133
| +33% | +$12.9M | 2.95% | 16 |
|
|
2019
Q1 | $28.3M | Buy |
323,677
+77,429
| +31% | +$6.77M | 1.87% | 24 |
|
|
2018
Q4 | $24.6M | Buy |
246,248
+77,319
| +46% | +$7.74M | 2.52% | 16 |
|
|
2018
Q3 | $19.4M | Sell |
168,929
-397,860
| -70% | -$45.6M | 2.16% | 24 |
|
|
2018
Q2 | $50.8M | Sell |
566,789
-369,507
| -39% | -$33.1M | 5.69% | 4 |
|
|
2018
Q1 | $68.5M | Sell |
936,296
-26,531
| -3% | -$1.94M | 7.53% | 4 |
|
|
2017
Q4 | $55.9M | Buy |
962,827
+127,193
| +15% | +$7.39M | 6.64% | 5 |
|
|
2017
Q3 | $37.5M | Buy |
835,634
+249,874
| +43% | +$11.2M | 6.21% | 4 |
|
|
2017
Q2 | $23.1M | Buy |
585,760
+135,276
| +30% | +$5.34M | 4.6% | 8 |
|
|
2017
Q1 | $18.3M | Buy |
450,484
+37,362
| +9% | +$1.52M | 4.78% | 9 |
|
|
2016
Q4 | $16.6M | Buy |
413,122
+61,289
| +17% | +$2.46M | 4.78% | 9 |
|
|
2016
Q3 | $12.7M | Buy |
351,833
+56,911
| +19% | +$2.06M | 5.13% | 8 |
|
|
2016
Q2 | $8.55M | Buy |
294,922
+112,312
| +62% | +$3.26M | 4.08% | 11 |
|
|
2016
Q1 | $6.39M | Buy |
182,610
+11,387
| +7% | +$398K | 3.31% | 13 |
|
|
2015
Q4 | $5.52M | Buy |
+171,223
| New | +$5.52M | 3.13% | 14 |
|